Mortality From Ischemic Heart Disease.
Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. · 2019
Read Mortality From Ischemic Heart Disease. by Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6613716.txt.
Introduction
Nowbar and co-authors chart deaths from ischemic heart disease across countries. Their study appears in Circulation: Cardiovascular Quality and Outcomes. The disease is often called the world's top killer. Yet national rates differ sharply, and trends shift over time. The team set out to map those gaps.
The authors analyzed death data sent to the World Health Organization. The data cover 2005 to 2015. Russia, the United States, and Ukraine had the most deaths overall. Age-adjusted rates were far higher in Ukraine and Kazakhstan. Rates sat much lower in Britain, Brazil, and the United States. All five focus countries saw steady declines in heart deaths. Smoking and high blood pressure fell with them. Obesity and type 2 diabetes rose everywhere, a warning for future gains.
Catalog record
| CREATOR | Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mortality From Ischemic Heart Disease By Alexandra N. Nowbar, Mauro Gitto, James P. Howard, Darrel P. Francis, Rasha Al-Lamee Published in: Circulation. Cardiovascular Quality and Outcomes DOI: 10.1161/CIRCOUTCOMES.118.005375 ABSTRACT Background: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. Methods and Results: We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual countries. We explored patterns in relationships with age, sex, and income and calculated age-standardized mortality rates for each country in addition to crude death rates. In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lower respiratory tract diseases) and examined the simultaneous trends in important cardiovascular risk factors. Russia, United States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data. Among 5 illustrative countries (United Kingdom, United States, Brazil, Kazakhstan, and Ukraine), IHD was the top cause of death, but mortality from IHD has progressively decreased from 2005 to 2015. Age-standardized IHD mortality rates per 100 000 people per year were much higher in Ukraine (324) and Kazakhstan (97) than in United States (60), Brazil (54), and the United Kingdom (46), with much less difference in other causes of death. All 5 countries showed a progressive decline in IHD mortality, with a decline in smoking and hypertension and in all cases a rise in obesity and type II diabetes mellitus. Conclusions: IHD remains the single largest cause of death in countries of all income groups. Rates are different between countries and are falling in most countries, indicating great potential for further gains. On the horizon, future improvements may become curtailed by increasing hypertension in some developing countries and more importantly global growth in obesity. WHAT IS KNOWNIschemic heart disease (IHD) is the primary cause of death globally with a recognized set of risk factors.WHAT THE STUDY ADDSIHD remains the leading cause of death in countries of all income groups.Ukraine and Kazakhstan have particularly high age-standardized mortality rates from IHD, which corresponds to a markedly high prevalence of smoking and hypertension in these countries.Although IHD rates are decreasing globally, risk factor prevalence is rising.The political and economic transitions that have taken place in Eastern Europe and Central Asia may have contributed to trends in IHD mortality and risk factor control. Ischemic heart disease (IHD) is the main global cause of death, accounting for >9 million deaths in 2016 according to the World Health Organization (WHO) estimates.1 Mortality from IHD in Western countries has dramatically decreased throughout the last decades with greater focus on primary prevention and improved diagnosis and treatment of IHD. However, developing countries pose new challenges for public health. While globalization often improves health care systems, the adoption of Western lifestyles can lead to higher prevalence of cardiovascular risk factors. We have previously studied the global epidemiology of IHD from 1995 to 2012.2,3 In this article, we provide an update, reporting on the burden of IHD mortality up to 2015. Mortality data will be presented by country, sex, and income. We provide additional country-based analyses of mortality rates by sex, mortality rate changes over time, and risk factors. We display how trends of mortality from IHD in these countries have evolved over the last decade, comparing them with mortality from the major noncommunicable diseases (NCDs) described by the WHO alongside liver disease, infectious disease, and transport accidents as points of reference. Governments worldwide are trying to address risk factors of NCDs.4 Therefore, we also analyze how the prevalence of hypertension, smoking, obesity, and diabetes mellitus has changed during these years. METHODS Data Sources The data that support the findings of this study are available from the corresponding author on reasonable request. The data are drawn from publically available sources, and there is no personally identifiable information about individuals. Therefore, no ethical approval was required for this study. We used mortality and population data2,3 submitted by individual countries to the WHO, in International Classification of Diseases-Ninth Revision or International Classification of Diseases-Tenth Revision formats, combined with the United Nations Population Division data query and Gross National Income (GNI) per capita from the World Bank list of economies.5,6 However, while other countries may collect vital registration data if countries did not provide data to the WHO, we were unable to include them in the analysis. GNI was defined as the sum of incomes of residents of an economy in a given period. Using the 2017 thresholds, countries were classified into high-income (GNI US $12 057 or higher), upper-middle income (GNI between US $3896 and US $12 056), lower-middle income (GNI between US $996 and US $3895), and low income (GNI US $995 or lower). Additionally, the NCD Risk Factor Collaboration data set was used to assess the prevalence of hypertension, diabetes mellitus, and the mean adult population body mass index (BMI) in selected countries.7 NCD Risk Factor Collaboration is a network of health scientists around the world. Their data set is based on population-based surveys with ≈129 million participants worldwide whose risk factor levels have been measured. Smoking prevalence data were collected from the WHO Global Health Observatory data repository.8 Rates of statin prescription among the adult population in the United Kingdom were taken from the Health Improvement Network primary care data.9 Data about prevalence of hypertension, obesity, and type II diabetes mellitus were available for all the countries that had provided IHD mortality data. Data about prevalence of smoking were available for all the countries that had provided IHD mortality data, except Hong Kong SAR, Turkmenistan, and Nicaragua. Age-Standardized Mortality Rates IHD deaths were standardized to the WHO World Standard Population, to allow comparison between populations with a different age distribution.10 All the countries that reported mortality data had age information to standardize the rates. Age-standardized mortality rates were calculated using mortality and population data reported within 5-year group ranges. The small number of deaths in the unspecified age group was excluded from this analysis. Age-Standardized Mortality Rates Over Time—the 16-Country Analysis Sixteen countries that had provided the most complete longitudinal data were selected to display trends in age-standardized mortality rates from 2005 to 2015. Five-Country Analysis About Sex Differences in Mortality From IHD, NCDs and Risk Factors Five countries were chosen across a range of geographies and income categories. The United States and United Kingdom were selected as 2 highly populated high-income countries with different healthcare systems and public health strategies. Ukraine, Kazakhstan, and Brazil were then included from low- to high-income categories across a range of continents and healthcare systems. The prevalence of hypertension, type II diabetes mellitus, and smoking, as well as the mean BMI, were assessed, using the same methods for standardization described above. Hypertension was defined as a systolic blood pressure higher than 140 mm Hg and a diastolic blood pressure lower than 90 mm Hg. Type II diabetes mellitus was defined as fasting plasma glucose of 7.0 mmol/L or higher or history of diabetes mellitus diagnosis or use of insulin or oral hypoglycemic drugs.7 For smoking, current tobacco smoking prevalence among people aged 15 years or more was